News

The Manila Times59m
Immunotherapeutic Targets for Recurrent Medulloblastoma Receives $85K Grant from Brain Cancer Canada
Medulloblastoma (MB) is the most common malignant brain tumour in children and is classified into four subgroups, with Group ...